Mumbai: Sun Pharmaceutical Industries Limited has entered into an agreement with Zaza Industrial Holdings K.K, Japan, under ...

Sonidegib phosphate is under clinical development by Sun Pharma Advanced Research and currently in Phase I for Hepatocellular Carcinoma.

India’s Sun Pharma has signed an agreement to take full control of Israeli generic drugmaker Taro Pharmaceutical Industries, taking it into private hands. New York Stock Exchange (NYSE)-listed ...

In the same year, Sun Pharma opened its first manufacturing facility for the production of tablets and capsules at Vapi, Gujarat, India. Initially, the company manufactured five psychiatry products.

Sun Pharmaceutical Industries Ltd. 524715 shares inched down 0.12% to 1,846.95 Indian rupees Monday, on what proved to be an ...